Data for Metabolomic and lipidomic profiles in response to exogenous insulin and GLP-1 infusions during prolonged fasting (Study ST000107)
(Analysis AN000178)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C16:0 | 1.4049 | 1.1032 | 1.0197 | 0.7775 | 0.3092 | 1.0424 | 1.1869 | 1.1120 | 0.9703 | 1.1623 | 0.9697 | 0.7372 | 1.0807 | 0.3895 | 0.9162 |
C16:1n7 | 1.4236 | 0.8372 | 1.2095 | 0.5213 | 0.1772 | 1.2365 | 1.0551 | 1.4156 | 0.9655 | 1.3004 | 0.6776 | 0.5800 | 0.9411 | 0.2201 | 0.8902 |
C17:0 | 1.2626 | 1.0548 | 1.1128 | 1.0542 | 0.3256 | 1.0822 | 1.1460 | 0.9918 | 1.0458 | 1.0573 | 0.9593 | 0.8684 | 0.9279 | 0.4497 | 0.9556 |
C18:0 | 1.1620 | 1.1990 | 1.0665 | 1.3017 | 0.5305 | 0.9800 | 1.0867 | 0.9167 | 1.0446 | 0.9438 | 1.0165 | 0.7823 | 1.0643 | 0.8364 | 1.0181 |
C18:1n7 | 1.5120 | 1.1506 | 1.1191 | 0.7083 | 0.1654 | 1.1641 | 1.2240 | 1.0943 | 1.0169 | 1.1750 | 0.7475 | 0.6140 | 0.9205 | 0.2196 | 0.8769 |
C18:1n9 | 1.4459 | 1.1452 | 1.0860 | 0.7645 | 0.1296 | 1.2098 | 1.2887 | 1.1399 | 1.0937 | 1.1604 | 0.7099 | 0.5028 | 0.8351 | 0.1910 | 0.8424 |
C18:2n6 | 1.4428 | 1.1948 | 1.1971 | 0.7769 | 0.2228 | 1.1106 | 1.1925 | 1.1107 | 1.0625 | 1.1094 | 0.7532 | 0.5613 | 0.8975 | 0.3143 | 0.9259 |
C18:3n3 | 1.3157 | 0.8219 | 1.3425 | 0.4944 | 0.2435 | 1.2252 | 1.0848 | 1.2388 | 0.9917 | 1.2278 | 0.6208 | 0.5560 | 0.9532 | 0.1920 | 0.7853 |
C20:1n9 | 1.5160 | 1.4179 | 1.2841 | 0.9109 | 0.1592 | 1.2195 | 1.1755 | 0.8719 | 1.1679 | 0.9546 | 0.7990 | 0.6006 | 0.7335 | 0.2929 | 1.0524 |
C20:3n6 | 1.5629 | 1.0541 | 0.9696 | 0.9738 | 0.7921 | 0.7821 | 0.8650 | 0.9843 | 0.9662 | 1.2476 | 1.0993 | 0.9291 | 0.9644 | 0.8862 | 1.0522 |
C20:4n6 | 1.1629 | 1.2669 | 1.0955 | 0.9620 | 0.6610 | 0.8796 | 1.0295 | 0.9949 | 1.0029 | 1.1804 | 0.8765 | 0.7936 | 0.9018 | 0.8360 | 1.1673 |
C20:5n3 | 1.1787 | 0.7348 | 1.0394 | 0.5025 | 0.4329 | 1.2133 | 1.0172 | 1.3619 | 1.0103 | 1.2121 | 0.9283 | 0.7401 | 1.1342 | 0.3690 | 0.6810 |
C22:5n3 | 1.2637 | 1.1003 | 1.1297 | 0.6920 | 0.2739 | 1.0454 | 1.1721 | 1.1763 | 1.1960 | 1.2529 | 0.7442 | 0.6719 | 0.6588 | 0.2968 | 1.0016 |
C22:6n3 | 1.1191 | 1.0611 | 1.2615 | 0.8301 | 0.6107 | 1.0118 | 1.0735 | 0.9877 | 1.0322 | 1.1229 | 1.0305 | 0.8146 | 0.9228 | 0.6497 | 1.0933 |
Factors:
F1 | Treatment:Early ITT Infusion Study | Timepoint:0 mins |
F2 | Treatment:Early ITT Infusion Study | Timepoint:10 mins |
F3 | Treatment:Early ITT Infusion Study | Timepoint:120 mins |
F4 | Treatment:Early ITT Infusion Study | Timepoint:30 mins |
F5 | Treatment:Early ITT Infusion Study | Timepoint:60 mins |
F6 | Treatment:GLP1/Late GTT | Timepoint:0 mins |
F7 | Treatment:GLP1/Late GTT | Timepoint:10 mins |
F8 | Treatment:GLP1/Late GTT | Timepoint:120 mins |
F9 | Treatment:GLP1/Late GTT | Timepoint:30 mins |
F10 | Treatment:GLP1/Late GTT | Timepoint:60 mins |
F11 | Treatment:Late ITT Infusion Study | Timepoint:0 mins |
F12 | Treatment:Late ITT Infusion Study | Timepoint:10 mins |
F13 | Treatment:Late ITT Infusion Study | Timepoint:120 mins |
F14 | Treatment:Late ITT Infusion Study | Timepoint:30 mins |
F15 | Treatment:Late ITT Infusion Study | Timepoint:60 mins |